$1.26 Billion is the total value of Redmile Group, LLC's 51 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 57.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARRY | Sell | ARRAY BIOPHARMA INC | $112,442,000 | +64.9% | 16,658,072 | -13.0% | 8.94% | +37.3% |
| SGEN | Buy | SEATTLE GENETICS INC | $96,217,000 | +72.4% | 1,781,470 | +29.0% | 7.65% | +43.5% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $94,361,000 | +55.6% | 12,751,536 | +14.8% | 7.50% | +29.6% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $73,902,000 | +73.9% | 2,049,985 | -33.8% | 5.88% | +44.8% |
| GWPH | New | GW PHARMACEUTICALS PLCads | $72,460,000 | – | 545,922 | +100.0% | 5.76% | – |
| INCY | Buy | INCYTE CORP | $56,351,000 | +133.1% | 597,638 | +97.7% | 4.48% | +94.0% |
| PEN | Sell | PENUMBRA INC | $51,135,000 | -0.5% | 672,918 | -22.1% | 4.07% | -17.1% |
| MOH | Sell | MOLINA HEALTHCARE INC | $45,382,000 | +7.6% | 778,160 | -7.9% | 3.61% | -10.4% |
| ELGX | Sell | ENDOLOGIX INC | $44,552,000 | -9.8% | 3,480,644 | -12.2% | 3.54% | -24.9% |
| PBYI | New | PUMA BIOTECHNOLOGY INC | $44,406,000 | – | 662,286 | +100.0% | 3.53% | – |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $43,242,000 | -20.3% | 2,021,617 | -16.1% | 3.44% | -33.6% |
| PRTA | Buy | PROTHENA CORP PLC | $42,078,000 | +146.9% | 701,659 | +44.0% | 3.35% | +105.6% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $39,327,000 | – | 640,400 | +100.0% | 3.13% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $38,976,000 | – | 737,900 | +100.0% | 3.10% | – |
| CNC | Buy | CENTENE CORP DEL | $31,075,000 | +52.7% | 464,077 | +62.8% | 2.47% | +27.2% |
| ARIA | New | ARIAD PHARMACEUTICALS INC | $29,276,000 | – | 2,138,471 | +100.0% | 2.33% | – |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $25,529,000 | -11.2% | 1,072,638 | -12.8% | 2.03% | -26.1% |
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $24,724,000 | +0.7% | 1,237,435 | -36.5% | 1.97% | -16.2% |
| NVRO | Sell | NEVRO CORP | $23,724,000 | -19.3% | 227,267 | -43.0% | 1.89% | -32.8% |
| OPHT | New | OPHTHOTECH CORP | $23,303,000 | – | 505,154 | +100.0% | 1.85% | – |
| ALDR | New | ALDER BIOPHARMACEUTICALS INC | $23,022,000 | – | 702,539 | +100.0% | 1.83% | – |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $22,788,000 | +0.5% | 701,822 | -35.9% | 1.81% | -16.3% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $20,823,000 | -39.8% | 916,927 | -37.5% | 1.66% | -49.9% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $17,975,000 | +39.9% | 1,431,119 | +0.2% | 1.43% | +16.4% |
| CMRX | Sell | CHIMERIX INC | $17,811,000 | +37.8% | 3,214,946 | -2.2% | 1.42% | +14.8% |
| MODN | Sell | MODEL N INC | $17,231,000 | -32.1% | 1,550,959 | -18.4% | 1.37% | -43.5% |
| BOLD | New | AUDENTES THERAPEUTICS INC | $14,903,000 | – | 916,626 | +100.0% | 1.18% | – |
| Sell | NEURODERM LTD | $14,889,000 | +11.5% | 805,246 | -2.0% | 1.18% | -7.1% | |
| SYRS | Sell | SYROS PHARMACEUTICALS INC | $11,736,000 | -22.1% | 892,782 | -5.6% | 0.93% | -35.1% |
| CTMX | Sell | CYTOMX THERAPEUTICS INC | $11,206,000 | +49.5% | 714,692 | -2.6% | 0.89% | +24.4% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $10,593,000 | -2.4% | 127,106 | -3.4% | 0.84% | -18.6% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $9,475,000 | – | 288,356 | +100.0% | 0.75% | – |
| SPNC | Sell | SPECTRANETICS CORP | $8,399,000 | +11.7% | 334,741 | -16.7% | 0.67% | -7.0% |
| IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $6,486,000 | +12.1% | 408,462 | -7.7% | 0.52% | -6.7% |
| WOOF | Sell | VCA INC | $6,368,000 | -0.0% | 91,000 | -3.4% | 0.51% | -16.8% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $5,565,000 | -76.5% | 45,410 | -77.6% | 0.44% | -80.4% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $5,132,000 | -86.4% | 336,759 | -65.3% | 0.41% | -88.7% |
| ARRAY BIOPHARMA INCnote 3.000% 6/0 | $4,761,000 | +40.8% | 4,000,000 | 0.0% | 0.38% | +17.3% | ||
| NVTA | Sell | INVITAE CORP | $4,471,000 | +11.0% | 510,369 | -6.3% | 0.36% | -7.5% |
| FATE | Sell | FATE THERAPEUTICS INC | $4,446,000 | +74.1% | 1,425,158 | -5.1% | 0.35% | +45.1% |
| PRQR | Sell | PROQR THRAPEUTICS N V | $3,841,000 | +36.4% | 575,863 | -1.0% | 0.30% | +13.4% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $818,000 | +42.5% | 27,539 | -2.9% | 0.06% | +18.2% |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $565,000 | +615.2% | 187,610 | +560.4% | 0.04% | +462.5% |
| FBT | New | FIRST TR EXCHANGE TRADED FDny arca biotech | $308,000 | – | 3,090 | +100.0% | 0.02% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $255,000 | – | 1,820 | +100.0% | 0.02% | – |
| HUM | New | HUMANA INC | $246,000 | – | 1,390 | +100.0% | 0.02% | – |
| BIIB | Sell | BIOGEN INC | $212,000 | -28.6% | 677 | -44.9% | 0.02% | -39.3% |
| DXCM | New | DEXCOM INC | $216,000 | – | 2,460 | +100.0% | 0.02% | – |
| AKAOQ | New | ACHAOGEN INC | $155,000 | – | 32,300 | +100.0% | 0.01% | – |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $91,000 | +30.0% | 22,236 | 0.0% | 0.01% | 0.0% | |
| CSLT | CASTLIGHT HEALTH INCcl b | $43,000 | +4.9% | 10,229 | 0.0% | 0.00% | -25.0% | |
| TMH | Exit | TEAM HEALTH HOLDINGS INC | $0 | – | -5,000 | -100.0% | -0.02% | – |
| LHCG | Exit | LHC GROUP INC | $0 | – | -5,000 | -100.0% | -0.02% | – |
| AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -25,000 | -100.0% | -0.03% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -250,830 | -100.0% | -0.24% | – |
| ARA | Exit | AMERICAN RENAL ASSOCIATES HO | $0 | – | -149,900 | -100.0% | -0.42% | – |
| EHTH | Exit | EHEALTH INC | $0 | – | -426,242 | -100.0% | -0.57% | – |
| PMC | Exit | PHARMERICA CORP | $0 | – | -263,862 | -100.0% | -0.62% | – |
| EVHC | Exit | ENVISION HEALTHCARE HLDGS IN | $0 | – | -288,918 | -100.0% | -0.70% | – |
| CFMS | Exit | CONFORMIS INC | $0 | – | -1,047,821 | -100.0% | -0.70% | – |
| PGND | Exit | PRESS GANEY HLDGS INC | $0 | – | -198,214 | -100.0% | -0.74% | – |
| ADPTQ | Exit | ADEPTUS HEALTH INCcl a | $0 | – | -163,474 | -100.0% | -0.81% | – |
| AET | Exit | AETNA INC NEW | $0 | – | -183,225 | -100.0% | -2.14% | – |
| HTWR | Exit | HEARTWARE INTL INC | $0 | – | -405,497 | -100.0% | -2.24% | – |
| BKD | Exit | BROOKDALE SR LIVING INC | $0 | – | -1,545,331 | -100.0% | -2.28% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -322,394 | -100.0% | -2.40% | – |
| XBI | Exit | SPDR SERIES TRUSTs&p biotech | $0 | – | -490,900 | -100.0% | -2.54% | – |
| MDVN | Exit | MEDIVATION INC | $0 | – | -929,529 | -100.0% | -5.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.